An overview of the efficacy and safety of β 2 -Adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease.
Maria Gabriella MateraPaola RoglianiLuigino CalzettaMario CazzolaPublished in: Expert opinion on drug safety (2024)
-AR antagonists in COPD, balancing cardiovascular benefits with potential respiratory risks to enhance outcomes and quality of life for individuals living with this debilitating respiratory condition.